$Marvell Technology(MRVL)$  I don't think this little pullback in Marvell Technologies will last long. The company has all the pieces, and once they get them aligned, the stock should be at $300.

$Marvell Technology(MRVL)$  Paper hands got shaken out, the market's riding on retail momentum now. Just waiting for the whales to breach the surface.

$Marvell Technology(MRVL)$  just delivered record-breaking earnings with raised guidance. Ditching the automotive cash cow to go all-in on AI? That's strategic focus, not weakness. Market's panic selling shows they can't see the forest for the trees.

With CXL Structura IP licensing, $Marvell Technology(MRVL)$  has essentially mirrored $ARM Holdings(ARM)$ 's architectural playbook, much like how $NVIDIA(NVDA)$  entrenched itself with CUDA software. Over time, this licensing model could become their most durable cash cow – not the chips they peddle, but the blueprints they lease. Sovereign memory scaffolding baked into the design, structurally similar to $NVIDIA(NVDA)$ 's approach.

Loaded up $Marvell Technology(MRVL)$  shares post-earnings dip, scooped LEAPs last Friday and doubled down this morning. This semi conductor play's like clockwork - always tanks after ER then bounces back to $80-$85 zone. Five-year chart shows it's been lagging behind peers. Trade the swings, not the fundamentals!

$Marvell Technology(MRVL)$ JPMorgan analyst is shouting from the rooftops about $Walt Disney(DIS)$  – load up on the dip while you can! Buy until your fingers bleed

$Marvell Technology(MRVL)$  Persistence wears down resistance, keep calm and carry on.

$Marvell Technology(MRVL)$ Persistent buying activity spotted in those $75 strike calls expiring 8/1

$Marvell Technology(MRVL)$  Looking for a push through 77.5 daily to add

$Marvell Technology(MRVL)$ $Advanced Micro Devices(AMD)$  and $NVIDIA(NVDA)$  plummeted right out the gate, looks like targeted strikes on semiconductor plays

$Marvell Technology(MRVL)$ OpenAI's adoption of $Alphabet(GOOGL)$ 's TPU really shows ASIC is the real MVP. When quarterly rebalancing comes, those fund managers will likely pump up $Marvell Technology(MRVL)$  positions - this small cap's been consolidating like a coiled spring. But I'm holding fire until July 3rd jobs data, reckon this runner could outpace $NVIDIA(NVDA)$ 's 4T bulk, with $Amazon.com(AMZN)$  tagging along for the ride.

$Marvell Technology(MRVL)$ Still accumulating at $100 level, three consecutive years of outsmarting those pin-striped Wall Street clowns - my track record speaks for itself

$Marvell Technology(MRVL)$ What a wake-up call! $Micron Technology(MU)$ 's stellar earnings got strangled by MM's option games, but I'll take $Marvell Technology(MRVL)$ 's rally any day. That 88-90 gap needs filling like yesterday, with 200 SMA glaring at 83.10. $Advanced Micro Devices(AMD)$ 's turn coming soon, mark my words.

$Marvell Technology(MRVL)$ Bloody miracle you kept your cool mate, uptrend's locked and loaded - full steam ahead

$Marvell Technology(MRVL)$  Finally clearing 80 resistance, still trading at chicken feed price

$Marvell Technology(MRVL)$ Rip face tomorrow.

$Micron Technology(MU)$ Who cares about short-term noise with $Advanced Micro Devices(AMD)$  $Marvell Technology(MRVL)$ ? These beauties are solid as a rock for long haul. Just buy and diamond hand the lot!

$Micron Technology(MU)$ As long as markets don't get jittery about these 20-year expansion blueprints, we're sitting pretty. This should give the whole semiconductor and AI gang a massive boost! $Advanced Micro Devices(AMD)$  $Marvell Technology(MRVL)$ 

$iShares Biotechnology ETF(IBB)$ Healthcare stocks have performed differently recently, but the IBB I bought is pretty good, which allowed me to make a small profit. I am holding on to it firmly and will keep going.

$Zai Lab Ltd(ZLAB)$ Feeling pretty good about ZLAB after the Q1 earnings. Revenue hit $106.5M，up 22% YoY，and they reaffirmed full-year guidance of $560M–$590M. What really impressed me? Super solid cost control on the sales side, and R&D spending stayed disciplined like in Q4. Product sales across the board are holding up well too. Strong execution, steady growth, this one's staying in my portfolio for the long game.